Showing results (231-240 of 302) with videos related to
Sort By:
Pageof 31
Schizophrenia Research|February 26, 2013
Effects of switching from olanzapine, quetiapine, and risperidone to aripiprazole on 10-year coronary heart disease risk and metabolic syndrome status: results from a randomized controlled trialT Scott Stroup, Matthew J Byerly, Henry A Nasrallah, et al.The British Journal of Psychiatry : the Journal of Mental Science|August 14, 2008
Comparison of antipsychotic medication effects on reducing violence in people with schizophreniaJeffrey W Swanson, Marvin S Swartz, Richard A Van Dorn, et al.The British Journal of Psychiatry : the Journal of Mental Science|July 3, 2007
Determining when impairment constitutes incapacity for informed consent in schizophrenia researchScott Y H Kim, Paul S Appelbaum, Jeffrey Swan, et al.The American Journal of Psychiatry|July 20, 2011
A randomized trial examining the effectiveness of switching from olanzapine, quetiapine, or risperidone to aripiprazole to reduce metabolic risk: comparison of antipsychotics for metabolic problems (CAMP)T Scott Stroup, Joseph P McEvoy, Kimberly D Ring, et al.Schizophrenia Bulletin|August 12, 2003
The National Institute of Mental Health Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) project: schizophrenia trial design and protocol developmentT Scott Stroup, Joseph P McEvoy, Marvin S Swartz, et al.Biological Psychiatry|July 31, 2009
Inflammatory markers in schizophrenia: comparing antipsychotic effects in phase 1 of the clinical antipsychotic trials of intervention effectiveness studyJonathan M Meyer, Joseph P McEvoy, Vicki G Davis, et al.The Medical Journal of Australia|September 21, 2004
Breast cancer in Western Australia: clinical practice and clinical guidelinesSuzanne P McEvoy, David M Ingram, Michael J Byrne, et al.Journal of Pediatric Surgery|June 19, 2012
Factors associated with relapse and survival in Wilms tumor: a multivariate analysisJoshua N Honeyman, Barrie S Rich, Maureen P McEvoy, et al.Psychiatric Services (Washington, D.C.)|July 28, 2006
Substance use and psychosocial functioning in schizophrenia among new enrollees in the NIMH CATIE studyMarvin S Swartz, H Ryan Wagner, Jeffrey W Swanson, et al.The Journal of Clinical Psychiatry|January 30, 2020
A Modified Delphi Consensus Study of the Screening, Diagnosis, and Treatment of Tardive DyskinesiaStanley N Caroff, Leslie Citrome, Jonathan Meyer, et al.Pageof 31